Evidence map›Paper›PMID 40496634›Full record

ArticleCase reports in endocrinology2025

Neoadjuvant Chemotherapy With Selpercatinib for Locally Advanced

Mei Kadoya, Katsuhiko Masudo, Hiroyuki Ito, Yoichiro Okubo, Yohei Miyagi, Hiroyuki Hayashi, Hiroyuki Iwasaki

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mei KadoyaDepartment of Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-2576-9946
Katsuhiko MasudoDepartment of Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Kanagawa, Japan.
Hiroyuki ItoDepartment of Respiratory Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Kanagawa, Japan.
Yoichiro OkuboDepartment of Pathology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-7079-4454
Yohei MiyagiDepartment of Pathology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-0056-7010
Hiroyuki HayashiDepartment of Pathology, Yokohama Municipal Citizen's Hospital, 1-1 Mitsuzawanishimachi, Kanagawa-Ku, Yokohama 221-0855, Kanagawa, Japan.
Hiroyuki IwasakiDepartment of Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-9724-8525

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 65-year-old male presented to our hospital with a complaint of a left cervical mass. The left supraclavicular lymph node was enlarged, measuring 77 mm, and biopsy results confirmed metastasis of papillary thyroid carcinoma (PTC). The left supraclavicular lymph node extended to the upper mediastinum and invaded the internal jugular and subclavian veins, with suspicion of common carotid and subclavian artery invasion. Surgical resection was deemed infeasible. The Oncomine Dx Target Test system, a gene panel test using a next-generation sequencer, of the metastatic lymph node was positive for

Identifiers

PMID40496634
PMCPMC12151616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.